Imaging Diagnostic Systems (fka IMDS)

[~ Blue ~]

Globe and Mail: IMDS Establishes Scientific Advisory Board

GlobeandMail (Canada's biggest newspaper)

Globe Investor


Imaging Diagnostic Systems Establishes Scientific Advisory Board

Monday, July 11, 2011 (FROM LAST YEAR but very good information about advisory BOARD MEMBERS)

FORT LAUDERDALE, Fla. (Business Wire) -- Imaging Diagnostic Systems, Inc., (OTCBB: IMDS) a pioneer in optical breast imaging, announced today that it has established a scientific advisory panel to assist with product advancement, future clinical studies and additional applications of its CT Laser Mammography breast imaging system.

The advisory panel will consist of leading physicians and scientists. IDSI will continue to expand the panel with medical and industry experts. The initial members are:


Huabei Jiang, Ph.D., J. Crayton Pruitt Professor in the J. Crayton Pruitt Family Department of Biomedical Engineering at the University of Florida

http://www.bme.ufl.edu/people/jiang_huabei

REMEMBER UNIVERSITY OF FLORIDA USES CTLM


page 7 first paragraph

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8632452




Alexander Poellinger, MD is head of the Outpatient's Care Center of Charitè Hospital, (Radiology) in Berlin



Read more: Imaging Diagnostic Systems Announces German University Study Aimed at Expanding the Clinical Utility of Its CTLM Laser Breast Im - FierceBiotech http://www.fiercebiotech.com/press-releases/imaging-diagnostic-systems-announces-german-university-study-aimed-expanding-clinical#ixzz1yIOEit3I
Subscribe: http://www.fiercebiotech.com/signup?sourceform=Viral-Tynt-FierceBiotech-FierceBiotech




Eric Milne, MD, FFR, FRCP, FRCP&S, was IDSI's Director of Clinical Research, former Chairman of Radiology and Chief of Chest Radiology at UC Irvine.

“The scientific advisory panel will be a valuable resource for IDSI in designing clinical studies, suggesting product improvements, and proposing new applications for CTLM technology. They will also assist with training development and participate in our international users meetings,” stated Dr. Steven Ponder, IDSI Director of Advanced Development.

About Imaging Diagnostic Systems, Inc.

Imaging Diagnostic Systems, Inc. has developed a revolutionary new imaging device to aid in the detection and management of breast cancer. The CTLM system is a breast imaging system that utilizes patented continuous wave laser technology and computer algorithms to create 3-D images of the breast. The procedure is non-invasive, painless, and does not expose the patient to ionizing radiation or painful breast compression. It reveals information about blood distribution in the breast and may visualize the process of angiogenesis; indicative of breast cancer.

Imaging Diagnostic Systems is currently in the FDA approval process for the Computed Tomography Laser Mammography system. The CTLM system is limited by United States Federal Law to investigational use only in the United States. The CTLM system has received other registrations including CE, CMDCAS Canadian License, China SFDA, UL, ISO 9001:2000, ISO 13485:2003 and FDA export certification.

For more information, visit our website: http://www.imds.com.


http://www.theglobeandmail.com/globe-investor/news-sources/?date=20110711&archive=bwire&slug=20110711006078